Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Medtronic
US Army
Citi
Harvard Business School
US Department of Justice
McKinsey
Chinese Patent Office

Generated: July 16, 2018

DrugPatentWatch Database Preview

Halofantrine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for halofantrine hydrochloride and what is the scope of halofantrine hydrochloride patent protection?

Halofantrine hydrochloride
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for halofantrine hydrochloride
Synonyms for halofantrine hydrochloride
(+-)-Halofantrine hydrochloride
1-(1,3-Dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol hydrochloride
1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl
1-[1,3-dichloro-6-trifluoromethyl-9-phenanthryl]-3-di(n-butyl)aminopropanol hydrochloride
1,3-Dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene HCl
1,3-Dichloro-a-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrenemethanol hydrochloride
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol hydrochloride
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol hydrochloride
1,3-DICHLORO-ALPHA-[2-(DIBUTYLAMINO)ETHYL]-6-(TRIFLUOROMETHYL)-9-PHENANTHRENEMETHANOL HYDROCHLORIDE
106927-11-1
167H632
2B7ENL644K
3-(Dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol hydrochloride
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride
3-DIBUTYLAMINO-1-(1,3-DICHLORO-6-TRIFLUOROMETHYL-PHENANTHREN-9-YL)-PROPAN-1-OL HCL
36167-63-2
9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-,hydrochloride
AC1L1XMK
AKOS030254762
API0002884
C-34958
C26H30Cl2F3NO.HCl
CAS-36167-63-2
CCG-221031
CHEMBL1200901
CTK8G0127
D02485
DSSTox_CID_25464
DSSTox_GSID_45464
DSSTox_RID_80895
DTXSID0045464
EINECS 252-895-4
FT-0082696
FT-0600399
Halfan (TN)
HALFAN HYDROCHLORIDE
Halofantrine HCl
Halofantrine hydrochlorid
Halofantrine hydrochloride (USAN)
Halofantrine Hydrochloride [USAN]
Halofantrine hydrochloride, >=98% (HPLC), solid
Halofantrine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Halofantrino
Halofantrino [Spanish]
HMS1571O03
LS-102675
MFCD00879136
MLS002154111
NCGC00016833-01
NCGC00179250-03
SCHEMBL466895
SK&F-102866
SKF 102886
SMR001233418
SR-01000841216
SR-01000841216-2
Tox21_110637
Tox21_110637_1
UNII-2B7ENL644K
W-106636
WR 171,699
WR 171669
WR-171,669
WR-171669
WR-171699
YF10095
Z3682

US Patents and Regulatory Information for halofantrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline HALFAN halofantrine hydrochloride TABLET;ORAL 020250-001 Jul 24, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
UBS
Federal Trade Commission
Farmers Insurance
Daiichi Sankyo
Cipla
Julphar
QuintilesIMS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.